OPRX
OptimizeRx Corporation
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$7.87
−1.01%Aug 12, 2026, 20:05 UTC
OptimizeRx announced the appointments of Andy D'Silva as Chief Financial Officer and Heather Favazza as Chief Accounting Officer, effective January 1, 2027.
Source:Aug 12, 2026, 20:01 UTC
OptimizeRx completed a debt refinancing with a $35 million traditional banking facility, including a $25 million term loan and a $10 million undrawn revolver, and repaid $8.3 million of principal since inception.
Source:Aug 12, 2026, 20:01 UTC
OptimizeRx reported second quarter 2026 financial results with revenue of $20.5 million, a net loss of $0.7 million, and adjusted EBITDA of $4.9 million.
Jun 30, 2026, 11:30 UTC
OptimizeRx launched CopayCue, a next-generation copay activation solution powered by real-time prescribing intent.
Source:Jun 25, 2026, 11:30 UTC
OptimizeRx launched its Natural Language Audience Builder (NLAB) technology for life sciences DSPs and agency media planning platforms.
Source:Jun 5, 2026, 00:00 UTC
Theresa Greco stepped down as Chief Commercial Officer of OptimizeRx Corp effective June 15, 2026, and will serve as an Advisor through June 15, 2027.